Maravai Lifesciences (MRVI) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $6.79, -3.96% vs the prior close of $7.07.
- Volume 2.22M shares, 0.6x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
MRVI slides 4.0% to $6.79. Closed at $6.79, -3.96% vs the prior close of $7.07. Day range $6.74–$7.07, opened at $7.05.
MRVI daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — MRVI slides 4.0% to $6.79
- Closed at $6.79, -3.96% vs the prior close of $7.07. Day range $6.74–$7.07, opened at $7.05.
- Volume was 2.22M shares, 0.6x its 50-day average of 3.52M.
- Price is -5.8% vs its 50-day average ($7.21) and +34.7% vs its 200-day average ($5.04).
- 52-week range $2.55–$9.42; today's close sits at 62% of that range, 27.9% below the 52-week high.
Oct 15, 2026 — MRVI jumps 7.9% to $7.07
- Closed at $7.07, +7.94% vs the prior close of $6.55. Day range $6.51–$7.15, opened at $6.70.
- Volume was 2.37M shares, 0.7x its 50-day average of 3.49M.
- Price is -1.8% vs its 50-day average ($7.20) and +40.7% vs its 200-day average ($5.02).
- 52-week range $2.55–$9.42; today's close sits at 66% of that range, 24.9% below the 52-week high.
Oct 14, 2026 — MRVI rises 0.3% to $6.55
- Closed at $6.55, +0.31% vs the prior close of $6.53. Day range $6.33–$6.67, opened at $6.41.
- Volume was 2.74M shares, 0.8x its 50-day average of 3.47M.
- Price is -8.8% vs its 50-day average ($7.18) and +30.9% vs its 200-day average ($5.00).
- 52-week range $2.55–$9.42; today's close sits at 58% of that range, 30.5% below the 52-week high.
Oct 13, 2026 — MRVI slides 7.5% to $6.53, a 1-month low
- Closed at $6.53, -7.51% vs the prior close of $7.06. Day range $6.52–$7.06, opened at $6.95.
- Volume was 4.33M shares, 1.3x its 50-day average of 3.42M.
- Price is -9.1% vs its 50-day average ($7.18) and +30.9% vs its 200-day average ($4.99).
- 52-week range $2.55–$9.42; today's close sits at 58% of that range, 30.7% below the 52-week high.
Oct 12, 2026 — MRVI slides 5.1% to $7.06
- Closed at $7.06, -5.11% vs the prior close of $7.44. Day range $6.95–$7.38, opened at $7.38.
- Volume was 1.25M shares, 0.4x its 50-day average of 3.42M — lighter than usual.
- Price is -1.7% vs its 50-day average ($7.18) and +42.0% vs its 200-day average ($4.97).
- 52-week range $2.55–$9.42; today's close sits at 66% of that range, 25.1% below the 52-week high.
Oct 9, 2026 — MRVI jumps 3.2% to $7.44
- Closed at $7.44, +3.19% vs the prior close of $7.21. Day range $7.17–$7.52, opened at $7.25.
- Volume was 2.30M shares, 0.7x its 50-day average of 3.40M.
- Price is +3.8% vs its 50-day average ($7.17) and +50.2% vs its 200-day average ($4.95).
- 52-week range $2.55–$9.42; today's close sits at 71% of that range, 21.0% below the 52-week high.
Oct 8, 2026 — MRVI dips 3.0% to $7.21, 3 down days in a row
- Closed at $7.21, -2.96% vs the prior close of $7.43. Day range $7.01–$7.37, opened at $7.31.
- Volume was 3.59M shares, 1.1x its 50-day average of 3.37M.
- Price is +0.8% vs its 50-day average ($7.16) and +46.1% vs its 200-day average ($4.93).
- 52-week range $2.55–$9.42; today's close sits at 68% of that range, 23.5% below the 52-week high.
- That makes 3 straight losses.
Oct 7, 2026 — MRVI slides 5.4% to $7.43
- Closed at $7.43, -5.35% vs the prior close of $7.85. Day range $7.22–$7.73, opened at $7.65.
- Volume was 4.27M shares, 1.3x its 50-day average of 3.33M.
- Price is +4.0% vs its 50-day average ($7.14) and +51.2% vs its 200-day average ($4.91).
- 52-week range $2.55–$9.42; today's close sits at 71% of that range, 21.1% below the 52-week high.
Oct 6, 2026 — MRVI slides 7.9% to $7.85
- Closed at $7.85, -7.86% vs the prior close of $8.52. Day range $7.76–$8.74, opened at $8.54.
- Volume was 3.61M shares, 1.1x its 50-day average of 3.30M.
- Price is +10.1% vs its 50-day average ($7.13) and +60.4% vs its 200-day average ($4.90).
- 52-week range $2.55–$9.42; today's close sits at 77% of that range, 16.7% below the 52-week high.
Oct 5, 2026 — MRVI jumps 7.8% to $8.52, a 1-month high
- Closed at $8.52, +7.85% vs the prior close of $7.90. Day range $7.80–$8.57, opened at $8.02.
- Volume was 2.63M shares, 0.8x its 50-day average of 3.29M.
- Price is +19.8% vs its 50-day average ($7.11) and +74.8% vs its 200-day average ($4.87).
- 52-week range $2.55–$9.42; today's close sits at 87% of that range, 9.6% below the 52-week high.
Oct 2, 2026 — MRVI jumps 5.3% to $7.90, a 1-month high
- Closed at $7.90, +5.33% vs the prior close of $7.50. Day range $7.50–$7.92, opened at $7.62.
- Volume was 1.91M shares, 0.6x its 50-day average of 3.29M — lighter than usual.
- Price is +11.7% vs its 50-day average ($7.07) and +62.9% vs its 200-day average ($4.85).
- 52-week range $2.55–$9.42; today's close sits at 78% of that range, 16.1% below the 52-week high.
MRVI latest news & SEC filings
Every SEC filing by or about MRVI in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 9, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Brust Bernd had withheld for taxes 29,250 shares at $7.43 (≈$217.33K) on Oct 8, 2026; now holds 1,531,999
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 1, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Asarpota Rajesh had withheld for taxes 5,465 shares at $7.65 (≈$41.81K) on Sep 30, 2026; now holds 418,021
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 29, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Sep 9, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 1, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 13, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 11, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 7, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $51.44M (prior year $47.40M) (+8.5% vs Jun 30, 2025)
- Net income: -$12.42M (prior year -$39.59M) (loss narrowed vs Jun 30, 2025)
- Diluted EPS: -$0.08 (prior year -$0.27) (loss narrowed vs Jun 30, 2025)
Aug 6, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Aug 3, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jun 29, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jun 23, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Things to know before you trade MRVI
- Last results release: Aug 6, 2026 (8-K Item 2.02). Previous ones: May 7, 2026, Feb 25, 2026, Nov 6, 2025. Based on that rhythm, the next report is likely around Nov 5, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 3.64% (largest 7.9%). That is a volatile stock.
- Liquidity: about 2.63M shares (≈$17.86M) trade per day on average.
- 52-week position: $6.79 vs a range of $2.55–$9.42 (62% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 17 open-market buys, 8 sales; latest: Kurt Oreshack sold 25,000 shares on Jun 10, 2026.
- Latest filings: 10-Q Aug 7, 2026; 8-K Aug 6, 2026; 8-K Jun 3, 2026.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
MRVI market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 7.05 | 7.07 | 6.74 | 6.79 | 2.22M |
| Oct 15, 2026 | 6.70 | 7.15 | 6.51 | 7.07 | 2.37M |
| Oct 14, 2026 | 6.41 | 6.67 | 6.33 | 6.55 | 2.74M |
| Oct 13, 2026 | 6.95 | 7.06 | 6.52 | 6.53 | 4.33M |
| Oct 12, 2026 | 7.38 | 7.38 | 6.95 | 7.06 | 1.25M |
| Oct 9, 2026 | 7.25 | 7.52 | 7.17 | 7.44 | 2.30M |
| Oct 8, 2026 | 7.31 | 7.37 | 7.01 | 7.21 | 3.59M |
| Oct 7, 2026 | 7.65 | 7.73 | 7.22 | 7.43 | 4.27M |
| Oct 6, 2026 | 8.54 | 8.74 | 7.76 | 7.85 | 3.61M |
| Oct 5, 2026 | 8.02 | 8.57 | 7.80 | 8.52 | 2.63M |
| Oct 2, 2026 | 7.62 | 7.92 | 7.50 | 7.90 | 1.91M |
| Oct 1, 2026 | 7.67 | 7.73 | 7.32 | 7.50 | 4.34M |
| Sep 30, 2026 | 7.65 | 7.75 | 7.53 | 7.66 | 3.61M |
| Sep 29, 2026 | 7.52 | 7.70 | 7.43 | 7.65 | 1.76M |
| Sep 28, 2026 | 7.49 | 7.68 | 7.40 | 7.63 | 1.94M |
| Sep 25, 2026 | 7.61 | 7.65 | 7.24 | 7.60 | 1.93M |
| Sep 24, 2026 | 7.35 | 7.76 | 7.31 | 7.65 | 2.39M |
| Sep 23, 2026 | 7.42 | 7.48 | 7.13 | 7.37 | 1.55M |
| Sep 22, 2026 | 7.18 | 7.49 | 6.99 | 7.46 | 1.57M |
| Sep 21, 2026 | 7.00 | 7.24 | 6.92 | 7.17 | 2.30M |
About Maravai Lifesciences
Maravai Lifesciences (MRVI) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in SAN DIEGO, CA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1823239.
MRVI board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Bernd Brust | Chief Executive Officer | Sep 9, 2026 |
| Sean Laurence Cunningham | Director | May 28, 2026 |
| John A Deford | Director | May 28, 2026 |
| R Andrew Eckert | Director | May 28, 2026 |
| Susannah Gray | Director | May 28, 2026 |
| Gregory T Lucier | Director | Jun 10, 2026 |
| Luke Joseph Marker | Director | May 28, 2026 |
| Constantine S Mihas | Director | May 28, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Rajesh Asarpota | Chief Financial Officer | Sep 1, 2026 |
| Bernd Brust | Chief Executive Officer | Sep 9, 2026 |
| Christine Dolan | See Remarks | May 22, 2026 |
| Kurt Oreshack | General Counsel | Jun 10, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jun 10, 2026 | Kurt Oreshack | Sale | 25,000 | $5.10 |
| Jun 10, 2026 | Kurt Oreshack | Sale | 25,000 | $5.10 |
| Jun 10, 2026 | Kurt Oreshack | Sale | 25,000 | $5.10 |
| Jun 10, 2026 | Kurt Oreshack | Sale | 25,000 | $5.10 |
| Jun 9, 2026 | Kurt Oreshack | Sale | 25,000 | $5.06 |
| Jun 9, 2026 | Kurt Oreshack | Sale | 25,000 | $5.06 |
| Jun 9, 2026 | Kurt Oreshack | Sale | 25,000 | $5.06 |
| Jun 9, 2026 | Kurt Oreshack | Sale | 25,000 | $5.06 |
| Dec 8, 2025 | Gregory T Lucier | Buy | 48,528 | $3.67 |
| Dec 8, 2025 | Gregory T Lucier | Buy | 48,528 | $3.67 |
| Dec 8, 2025 | Gregory T Lucier | Buy | 48,528 | $3.67 |
| Dec 8, 2025 | Gregory T Lucier | Buy | 48,528 | $3.67 |
| Dec 5, 2025 | Gregory T Lucier | Buy | 51,472 | $3.70 |
| Dec 5, 2025 | Gregory T Lucier | Buy | 51,472 | $3.70 |
| Dec 5, 2025 | Gregory T Lucier | Buy | 51,472 | $3.70 |
MRVI financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $185.74M | $-130.77M | -0.90 | $-57.57M |
| Dec 31, 2024 | $259.19M | $-144.85M | -1.05 | $7.46M |
| Dec 31, 2023 | $288.94M | $-119.03M | -0.90 | $126.22M |
| Dec 31, 2022 | $883.00M | $220.21M | 1.67 | $535.98M |
| Dec 31, 2021 | $799.24M | $182.04M | 1.56 | $368.57M |
Latest balance sheet: total assets $603.75M, total liabilities $248.16M, cash $70.09M (as of Jun 30, 2026).
MRVI earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 6, 2026 | 8-K Item 2.02 (results) | $6.25 |
| May 7, 2026 | 8-K Item 2.02 (results) | $3.94 |
| Feb 25, 2026 | 8-K Item 2.02 (results) | $3.26 |
| Nov 6, 2025 | 8-K Item 2.02 (results) | $2.89 |
| Aug 11, 2025 | 8-K Item 2.02 (results) | $2.06 |
| May 12, 2025 | 8-K Item 2.02 (results) | $2.12 |
| Mar 18, 2025 | 8-K Item 2.02 (results) | $2.58 |
| Feb 25, 2025 | 8-K Item 2.02 (results) | $3.14 |
| Jan 8, 2025 | 8-K Item 2.02 (results) | $6.13 |
| Nov 7, 2024 | 8-K Item 2.02 (results) | $7.84 |
| Aug 7, 2024 | 8-K Item 2.02 (results) | — |
| May 8, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on MRVI
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.